One River Asset Management’s AbbVie ABBV Stock Holding History

One River Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.06M	Sell	4,200 -400	-9%	-$86.1K	0.34%	70
2026 Q1	$1M	Buy	4,600 +700	+18%	+$155K	0.37%	65
2025 Q4	$891K	Sell	3,900 -500	-11%	-$114K	0.08%	121
2025 Q3	$1.02M	Buy	+4,400	New	+$896K	0.28%	71
2024 Q4	–	Sell	-1,600	Closed	-$316K	–	247
2024 Q3	$316K	Buy	+1,600	New	+$299K	0.04%	177

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

One River Asset Management's ABBV Position: Q2 2026 in Review

One River Asset Management sold out of AbbVie (ABBV) in Q2 2026, closing a stake of 896 shares — an estimated $193K sold.

One River Asset Management first reported a position in ABBV in Q4 2025 and held it in 2 quarters. The position peaked at $195K in Q1 2026. 4,225 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

One River Asset Management reported no remaining AbbVie position as of Q2 2026 after selling out during the quarter.
One River Asset Management sold 896 AbbVie shares in Q2 2026, an estimated $193K.
One River Asset Management first reported a position in AbbVie in Q4 2025 and held it in 2 quarters.
One River Asset Management's AbbVie position peaked at $195K in Q1 2026.
4,225 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on One River Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.